ArticleClinical advances in hematology & oncology : H&OPublished
Improving outcomes in pediatric NTRK gene fusion-positive solid tumors: importance of genomic testing and targeted therapy with the TRK inhibitor larotrectinib
Regional connection
Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Publication record
- Type
- Article
- Venue
- Clinical advances in hematology & oncology : H&O
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Pyrazoles; Pyrimidines; Pyrroles; Receptor, trkA; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Treatment Outcome; Child; Molecular Targeted Therapy
- PubMed ID
- 38739704
- Added to directory
- Source checked